Vidipha Central Pharmaceutical JSC banner
V

Vidipha Central Pharmaceutical JSC
VN:VDP

Watchlist Manager
Vidipha Central Pharmaceutical JSC
VN:VDP
Watchlist
Price: 32 400 VND -0.31% Market Closed
Market Cap: ₫1T

Wall St Price Targets

VDP Price Targets Summary
Vidipha Central Pharmaceutical JSC

There are no price targets for VDP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Vidipha Central Pharmaceutical JSC Competitors:
Price Targets
MAT
Mattel Inc
32% Upside
SNNP
Srinanaporn Marketing PCL
14% Upside

Revenue
Forecast

11% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is -10%.

Gross Profit
Forecast

13% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is -12%.

Operating Income
Forecast

12% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 18%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 8 years is -4%.

Net Income
Forecast

1% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is -4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VDP's stock price target?
Not Available

VDP does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Vidipha Central Pharmaceutical JSC?
Projected CAGR
-10%

Over the last 9 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is -10%.

What is the Gross Profit forecast for Vidipha Central Pharmaceutical JSC?
Projected CAGR
-12%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is -12%.

What is the Operating Income forecast for Vidipha Central Pharmaceutical JSC?
Projected CAGR
18%

Over the last 9 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 18%.

What is the Pre-Tax Income forecast for Vidipha Central Pharmaceutical JSC?
Projected CAGR
-4%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 8 years is -4%.

What is the Net Income forecast for Vidipha Central Pharmaceutical JSC?
Projected CAGR
-4%

Over the last 9 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is -4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett